National (Australia) HPV 3 dose vaccination coverage for females turning 15 years of age in 2015

State Estimated
Resident
Population
(as at
30/06/2015)
Coverage Dose 1 Coverage Dose 2 Coverage Dose 3 Total
Doses
n % n % n %
ACT 2,176 1,968 90.4% 1,892 86.9% 1,659 76.2% 5,519
NSW 44,476 38,882 87.4% 37,837 85.1% 35,855 80.6% 112,574
NT 1,566 1,522 97.2% 1,455 92.9% 1,351 86.3% 4,328
QLD 29,552 24,956 84.4% 24,184 81.8% 22,423 75.9% 71,563
SA 9,764 8,242 84.4% 7,942 81.3% 7,250 74.3% 23,434
TAS 3,168 2,645 83.5% 2,477 78.2% 2,165 68.3% 7,287
VIC 33,855 30,016 88.7% 28,945 85.5% 26,887 79.4% 85,848
WA 15,415 12,722 82.5% 12,355 80.1% 11,541 74.9% 36,618
NAT 139,972 120,953 86.4% 117,087 83.7% 109,131 78.0% 347,171


NOTES

  • Data extracted from the National HPV Vaccination Program Register (HPV Register) as at 12 JULY 2017 and includes females vaccinated between APR 2007 and JUN 2017.
  • Includes doses that comply with the recommended vaccine dosage and administration as per the Australian Immunisation Handbook (up to 3 doses administered at prescribed intervals).
  • Population is Estimated Resident Population (ERP) provided by the Australian Bureau of Statistics - CAT 3101.0 Australian Demographics Statistics, Tables 51 to 58 - Estimated Resident Population by Single Year of Age by State and Territory, PRELIMINARY data published DEC 2016.
  • Age is age as at date of ERP estimate (30th June).
  • Coverage is calculated as doses administered and reported to the HPV Register/Estimated Resident Population expressed as a percentage.
  • Excludes consumers who do not wish their details to be recorded on the HPV Register.
  • The National HPV Vaccination Program initially provided quadrivalent HPV vaccine for all females aged 12-26 years as at mid 2007 ( school program commenced April 2007 and GP/community program in July 2007) until end December 2009. From 2009 the Program offered HPV vaccination routinely to females in the first year of high school (usually at 12-13 years). From 2013, males were also offered HPV vaccination routinely in the first year of high school (age 12-13 years), with a catch-up program available for males aged 14-15 years in 2013 and 2014.
  • As the ages of students in the first year of high school varies between jurisdictions, age 15 is used as the age for routine review of vaccination coverage that provides the best comparison to allow for these varying ages in administration, as per World Health Organization (WHO) recommendations.
  • HPV Vaccination doses administered through general practice and in other community settings may be incompletely notified to the HPV Register. The extent of under notification differs by jurisdiction, with the Northern Territory and Queensland expected to have the most complete notification, due to notification of doses via State based immunisation registers.